ADC Therapeutics S.A. (ADCT)
NYSE·Healthcare·Biotechnology
$3.74
-0.66%
Mkt Cap $501.13M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $22.30M | $23.06M | +3.40% | -$0.32 | -$0.04 | +87.50% | — | — |
| Q4 2025 Nov 10, 2025 | $21.57M | $16.43M | -23.84% | -$0.40 | -$0.30 | +25.00% | — | — |
| Q3 2025 Aug 12, 2025 | $18.19M | $18.84M | +3.55% | -$0.36 | -$0.50 | -38.89% | — | — |
| Q2 2025 May 14, 2025 | $17.55M | $23.03M | +31.28% | -$0.38 | -$0.36 | +5.26% | — | — |
| Q1 2025 Mar 27, 2025 | $19.01M | $16.91M | -11.03% | -$0.35 | -$0.29 | +17.14% | — | — |
| Q4 2024 Nov 7, 2024 | $18.85M | $18.46M | -2.05% | -$0.36 | -$0.42 | -16.67% | — | — |
| Q3 2024 Aug 6, 2024 | $18.48M | $17.41M | -5.79% | -$0.44 | -$0.38 | +13.64% | — | — |
| Q2 2024 May 6, 2024 | $18.10M | $18.05M | -0.26% | -$0.56 | -$0.56 | +0.00% | — | — |
| Q1 2024 Mar 13, 2024 | $15.33M | $16.79M | +9.52% | -$0.47 | -$1.03 | -119.15% | — | — |
| Q4 2023 Nov 7, 2023 | $15.39M | $14.49M | -5.83% | -$0.61 | -$0.58 | +4.92% | — | — |
| Q3 2023 Aug 8, 2023 | $41.55M | $19.28M | -53.59% | -$0.44 | -$0.58 | -31.82% | — | — |
| Q2 2023 May 9, 2023 | $32.38M | $18.99M | -41.35% | -$0.80 | -$0.74 | +7.50% | — | — |
| Q1 2023 Feb 28, 2023 | $20.09M | $69.80M | +247.43% | -$0.49 | -$0.30 | +38.78% | — | — |
| Q4 2022 Nov 8, 2022 | $60.70M | $76.32M | +25.74% | -$0.51 | -$0.65 | -27.45% | — | — |
| Q3 2022 Aug 9, 2022 | $31.22M | $17.29M | -44.62% | -$0.96 | -$0.73 | +23.96% | — | — |
| Q2 2022 May 9, 2022 | $37.12M | $46.50M | +25.28% | -$0.76 | -$0.36 | +52.63% | — | — |
| Q1 2022 Mar 3, 2022 | $16.47M | $17.01M | +3.25% | -$0.87 | -$0.39 | +55.17% | — | — |
| Q4 2021 Nov 2, 2021 | $7.24M | $13.15M | +81.59% | -$0.97 | -$0.59 | +39.18% | — | — |
| Q3 2021 Aug 3, 2021 | $3.76M | $3.76M | +0.00% | -$0.84 | -$0.70 | +16.67% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$1.00 | -$0.74 | +26.00% | — | — |